Phase I Trial of Pirfenidone in Children with Neurofibromatosis 1 and Plexiform Neurofibromas
- 31 May 2007
- journal article
- Published by Elsevier
- Vol. 36 (5) , 293-300
- https://doi.org/10.1016/j.pediatrneurol.2007.01.009
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Desmoid tumors in familial adenomatous polyposis: a pilot project evaluating efficacy of treatment with pirfenidoneAmerican Journal of Gastroenterology, 2003
- Open-label Compassionate Use One Year-treatment with Pirfenidone to Patients with Chronic Pulmonary Fibrosis.Internal Medicine, 2002
- Mortality in Neurofibromatosis 1: An Analysis Using U.S. Death CertificatesAmerican Journal of Human Genetics, 2001
- Malignancy in Neurofibromatosis Type 1The Oncologist, 2000
- Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With PirfenidoneBioMed Research International, 2000
- Plexiform neurofibromasAmerican Journal of Medical Genetics, 1999
- Prognostic signs in the surgical management of plexiform neurofibroma: The Children’s Hospital of Philadelphia experience, 1974-1994Published by Elsevier ,1997
- The Growth Regulation of Neurofibroma Cells in Neurofibromatosis Type-1: Increased Responses to PDGF-BB and TGF-β1Biochemical and Biophysical Research Communications, 1994
- Growth and Collagen Synthesis of Cultured Neurofibroma FibroblastsThe Journal of Dermatology, 1992
- VON RECKLINGHAUSEN NEUROFIBROMATOSISBrain, 1988